Dr. McArdle's research primarily studies Lyme disease and its long-term effects on patients, highlighting the need for better diagnostic methods and follow-up care. He also investigates how environmental factors, such as chemicals in water, can impact human and ecological health. Additionally, he examines social behaviors during health crises like the COVID-19 pandemic and explores innovative treatments for mental health issues in patients with chronic conditions, such as chronic kidney disease.
Key findings
In a 10-year study on Lyme disease, only 34% of patients with a specific skin rash tested positive, and 22% continued to experience symptoms like joint pain despite treatment.
BPA levels in freshwater were found to range from less than 0.03 to 588,000 nanograms per liter, with an average of 36 nanograms, showing improvements in water quality over time.
A program aimed at improving mental health in patients with chronic kidney disease showed promise in reducing anxiety and depression levels, particularly during the challenges of the COVID-19 pandemic.
In stress testing, 11.5% of patients had elevated readings that indicated serious heart issues, with 14.3% experiencing ischemia and 10.9% requiring early revascularization.
A pilot study indicated that ondansetron potentially decreased depression symptoms in patients with bipolar disorder and early signs of alcohol use problems, with a significant improvement reflected in depression scores.
Frequently asked questions
Does Dr. McArdle study Lyme disease?
Yes, Dr. McArdle focuses on Lyme disease, looking at its symptoms, treatment effectiveness, and the need for better diagnostic methods.
What mental health treatments has Dr. McArdle researched?
He has researched the Compassionate Mindful Resilience program aimed at reducing anxiety and depression in patients with chronic kidney disease.
Is Dr. McArdle's work relevant to environmental health?
Yes, he studies the effects of environmental pollutants like Bisphenol A on water quality and its implications for public health.
How does Dr. McArdle's research help elderly patients?
His work on trauma in the elderly highlights the risks associated with falls and uncommon conditions, aiming to improve recognition and treatment.
What can be learned from Dr. McArdle's trauma care research?
His studies identify areas for improving trauma care quality, which can help reduce preventable deaths in hospital settings.
Publications in plain English
Trend analysis of environmental concentrations of Bisphenol A in European waters and sediments.
2025
Environmental research
Swansborough C, Soto J, Shapland I, Hughes CB, Jennings E +4 more
Plain English This study examined the levels of Bisphenol A (BPA), a chemical that might be harmful to health, in water and sediment across Europe from 2010 to 2022. The researchers found BPA levels in freshwaters ranging from less than 0.03 to 588,000 nanograms per liter, with the average being 36 nanograms per liter. Overall, BPA levels have decreased in freshwater and sediment over the studied years, which suggests improvements in water quality in some areas, especially in France and Germany.
Who this helps: This helps patients and environmental health advocates by providing important information on water safety and pollution trends.
Lyme Disease Biobank: 10 years of 3 month follow-up visits from 2014 to 2023.
2025
Frontiers in medicine
Horn EJ, Dempsey G, Schotthoefer AM, McArdle M, Weber AF +3 more
Plain English This study looked at people diagnosed with early Lyme disease over a ten-year period, examining symptoms and blood samples to improve testing methods. They found that only 34% of those with a specific skin rash tested positive using standard methods, and only 4% showed signs of recovery after treatment. Despite initial antibiotic treatment, 22% of participants continued to have symptoms like joint pain and fatigue, highlighting the need for better follow-up care and possibly re-treatment for those who still feel unwell.
Who this helps: This helps patients suffering from Lyme disease and healthcare providers treating them.
Changes in social norms during the early stages of the COVID-19 pandemic across 43 countries.
2024
Nature communications
Andrighetto G, Szekely A, Guido A, Gelfand M, Abernathy J +77 more
Plain English The study looked at how social behaviors and norms changed in 43 countries during the early COVID-19 pandemic. Researchers found that people started to wash their hands more often, with norms around hand-washing increasing, but overall cultural strictness and the frequency of punishment slightly decreased. This matters because it shows that while some behaviors adapted to the pandemic, most other social norms remained stable.
Who this helps: This helps public health officials and policymakers understand how to promote safe practices during health crises.
Trauma in the elderly: a bilateral rectus sheath haematoma.
2023
BMJ case reports
McArdle M
Plain English This study focuses on a rare medical condition called bilateral rectus sheath hematoma (RSH) that can occur in elderly patients after they suffer a fall. The researchers found that while RSH is uncommon, it can lead to serious complications and even death, particularly in older adults who may have other health issues. This matters because recognizing and treating these cases quickly is crucial for improving survival rates and outcomes among frail elderly patients.
Who this helps: This study benefits elderly patients and their healthcare providers.
Examining the Acceptability and Feasibility of the Compassionate Mindful Resilience (CMR) Programme in Adult Patients with Chronic Kidney Disease: The COSMIC Study Protocol.
2022
Healthcare (Basel, Switzerland)
Wilson A, McKeaveney C, Carswell C, Atkinson K, Burton S +10 more
Plain English This study looked at a program called the Compassionate Mindful Resilience (CMR) designed to help adults with severe kidney disease improve their mental health. It involved four sessions where patients learned mindfulness and self-compassion techniques. The aim was to see if this program could reduce anxiety and depression levels, as well as boost overall wellbeing, especially during the challenges brought on by the COVID-19 pandemic.
Who this helps: This helps patients with chronic kidney disease and kidney transplant recipients.
A randomized, double-blind, placebo-controlled proof-of-concept study of ondansetron for bipolar and related disorders and alcohol use disorder.
2021
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Sherwood Brown E, McArdle M, Palka J, Bice C, Ivleva E +5 more
Plain English This study looked at the effects of ondansetron, a medication, on people with both bipolar disorder and early signs of alcohol use problems. Researchers found that, while there were no significant changes in alcohol use, participants experienced a meaningful decrease in depression symptoms. Specifically, depression scores improved with a p-value of 0.045, indicating a potential benefit.
Who this helps: This research helps patients with bipolar disorder and alcohol use issues by exploring new treatment options for their depression.
Lead aVR predicts early revascularization but not long-term events in patients referred for stress electrocardiography.
2021
PloS one
Baheti A, Hanson CA, McArdle M, Lall SK, Beller GA +1 more
Plain English This study looked at a specific part of an electrocardiogram (ECG) called lead aVR to see if it could help predict heart issues in patients undergoing exercise stress testing. Researchers found that 11.5% of patients showed elevated aVR readings, which were strongly linked to significant heart problems: 14.3% of these patients had ischemia, and 10.9% underwent early revascularization (compared to just 0.2% without aVR elevation). However, over a median follow-up of four years, there was no difference in long-term cardiac events between those with and without aVR elevation.
Who this helps: This research helps doctors determine which patients might need more immediate intervention during stress testing.
Neuropsychological profile associated with Moyamoya disease: A case report.
2020
NeuroRehabilitation
Indorewalla KK, McArdle M, Tomlinson E, Piryatinsky I
Plain English This study focused on a 31-year-old woman with Moyamoya disease, a condition that affects blood flow in the brain, and looked at how it impacted her thinking and memory after she had a stroke and surgery. The tests showed that she struggled with attention, processing speed, memory, and planning, despite having resolved her speech and movement issues. This matters because it highlights that even after medical treatment, many patients with Moyamoya disease face ongoing cognitive challenges that can significantly affect their daily lives.
Who this helps: This helps patients with Moyamoya disease and their doctors understand the potential long-term cognitive effects of the condition.
The Lyme Disease Biobank: Characterization of 550 Patient and Control Samples from the East Coast and Upper Midwest of the United States.
2020
Journal of clinical microbiology
Horn EJ, Dempsey G, Schotthoefer AM, Prisco UL, McArdle M +11 more
Plain English This study examined samples from 550 people to better understand Lyme disease, focusing on those showing early symptoms and comparing them to uninfected individuals. They found that only 29% of patients with large skin lesions tested positive for Lyme disease using standard blood tests, highlighting the tests' limitations in early diagnosis. This research is important because improving early detection can lead to better treatment and outcomes for Lyme disease sufferers.
Who this helps: Patients with Lyme disease and healthcare providers looking to diagnose and treat the condition more effectively.
Nortriptyline-induced oral ulceration: A case report.
2018
The mental health clinician
Olsufka W, Cabral D, McArdle M, Kavanagh R
Plain English This study looked at a 49-year-old woman who developed painful mouth ulcers after starting nortriptyline, an antidepressant used for nerve pain. She started having symptoms two weeks into her treatment, which completely went away about a month after stopping the medication. Understanding that nortriptyline can cause such side effects is important for doctors to help manage and inform patients about their treatment options.
Who this helps: This helps patients and doctors by raising awareness of possible side effects from nortriptyline.
The dying of the light: mitochondrial failure in Alzheimer's disease.
2012
Journal of Alzheimer's disease : JAD
Young-Collier KJ, McArdle M, Bennett JP
Plain English This study looked at how Alzheimer's disease affects energy production in the brain by examining brain tissues from patients who passed away. They found that in Alzheimer's patients, energy production was reduced by about two-thirds compared to healthy individuals due to a loss of mitochondria, which are the energy factories of cells. Additionally, key proteins that usually help with energy production and protection from damage were at lower levels, suggesting that improving energy production and protection in brain cells might be important to slow down Alzheimer's.
Who this helps: This research helps patients with Alzheimer's disease and their caregivers.
Estrogenic and CYP1A response of mummichogs and sunshine bass to sewage effluent.
2000
Marine environmental research
McArdle M, Elskus A, McElroy A, Larsen B, Benson W +1 more
Plain English This study looked at how sewage treatment plant waste affects two types of fish: mummichogs and sunshine bass. The researchers found that sunshine bass exposed to the waste had a huge rise in a protein linked to reproduction (vitellogenin) by 1,730% in their blood and 131% in their liver, while mummichogs did not show elevated levels. These results highlight the different ways fish respond to sewage pollutants and suggest that these chemicals could impact their health and reproductive abilities.
Who this helps: This helps environmental scientists and fishery managers understand the risks of sewage pollution on aquatic life.
Plain English This study looked at a 15-year-old boy who experienced two episodes of aseptic meningitis after taking a medication called co-trimoxazole. The doctors concluded that the medication caused his symptoms. This finding is important because it helps identify a possible side effect of this common drug, ensuring better diagnosis and treatment for similar cases in the future.
Who this helps: Patients who are prescribed co-trimoxazole and their doctors.
Assuring quality in a trauma system--the Medical Audit Committee: composition, cost, and results.
1987
The Journal of trauma
Shackford SR, Hollingsworth-Fridlund P, McArdle M, Eastman AB
Plain English This study examined the quality of medical care in trauma systems by auditing nearly 8,000 cases over nearly two years. The findings showed that out of 224 deaths at non-trauma hospitals, 17 (7.6%) were considered preventable, while only 11 (2%) of 541 deaths at trauma centers were deemed preventable, highlighting that errors in diagnosis were a major issue at non-trauma hospitals. This information is important because it reveals areas for improvement in trauma care, which could save lives by addressing specific types of errors that lead to preventable deaths.
Who this helps: This helps patients and healthcare providers by identifying ways to improve trauma care quality.
Plain English This study looked at the role of trauma nurse coordinators, who are specialized nurses that help manage care for patients with severe injuries. The research found that these coordinators play a crucial role in not just providing care in hospitals, but also in working with government organizations to improve overall trauma care. This matters because better coordination can lead to improved patient outcomes and more efficient use of resources.
Who this helps: Patients with severe injuries and the healthcare teams that care for them.
Elizabeth J Horn George Dempsey Anna M Schotthoefer Cathy De Luca Bobbi S Pritt Allison F Weber Elizabeth L Maloney Chesney Swansborough Javier Soto Imogen Shapland
Physician data sourced from the
NPPES NPI Registry
.
Publication data from
PubMed
.
Plain-English summaries generated by AI.
Not medical advice.